Company Filing History:
Years Active: 2022
Title: Mary Elizabeth Walker: Innovator in Statin Efficacy Assessment
Introduction
Mary Elizabeth Walker is a notable inventor based in London, GB. She has made significant contributions to the field of medical research, particularly in the assessment of statin efficacy for treating inflammatory diseases. Her innovative approach combines advanced methodologies with practical applications in patient care.
Latest Patents
Mary Elizabeth Walker holds a patent for a method and apparatus designed to determine the efficacy of statins in treating inflammatory diseases in individual patients. The patent, which is her sole patent, outlines a comprehensive method, device, and computer program, along with a related immunoassay. This invention focuses on measuring the levels of specific 13-series resolvins in biological samples before and after statin administration. An increase in resolvin levels post-administration indicates the efficacy of the statin treatment.
Career Highlights
Mary is affiliated with the University of London, where she conducts her research and develops her innovative solutions. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from inflammatory conditions.
Collaborations
Mary has collaborated with esteemed colleagues, including Jesmond Dalli and Romain Alexandre Colas, to advance her research and enhance the impact of her inventions.
Conclusion
Mary Elizabeth Walker's contributions to the field of medical research through her innovative patent demonstrate her commitment to improving patient care. Her work in assessing statin efficacy is a testament to the importance of innovation in healthcare.